Silverman, Eric E.

Eric E. Silverman, PhD has over twenty years of intellectual property experience spanning a wide range of industries and technologies.  Eric started his IP career as a patent examiner at the USPTO, where he became a primary examiner of patent applications in technologies including pharmaceutical formulations, drug delivery, medical devices, implants, and cosmetics.  He then spent several years in large international law firms where his practice included IP litigation, prosecution, and due diligence in technologies such as pharmaceuticals, medical devices, solar power, petrochemicals, oil and gas, and ceramics.  Eric has practiced in-house for over a decade, first at 3M as a Director and Assistant Chief IP Counsel, where he supported patent acquisition, strategy, and conflicts, licensing, confidentiality and trade secrets for a variety of businesses including food safety, drug delivery, manufacturing technologies, adhesives, and green packaging.  He also served as IP counsel on several M&A transactions.  Eric moved from 3M to become Director, IP Counsel at BioMarin Pharmaceutical, where he oversaw the patent program for BioMarin’s small molecule assets as well as non-patent IP matters including copyright.  He is now a Senior IP Attorney at Genentech, Inc. (a member of the Roche Group), where his practice includes IP support for small molecule oncology programs as well as trade secrets.